Post-Closing Conditions. No later than the fifth (5th) day following the Closing Date, the Company shall cause the conversion of all of its issued and outstanding shares of its Series E and Series F stock into shares of Common Stock.
Appears in 5 contracts
Sources: Securities Purchase Agreement (Adhera Therapeutics, Inc.), Securities Purchase Agreement (Adhera Therapeutics, Inc.), Securities Purchase Agreement (Adhera Therapeutics, Inc.)